Abbott Laboratories
ABT | NYSE
$108.30
+$2.10 (+1.98%)
Nov 2, 2026, 9:46 AM ET · Market open
Market Data
Market Cap $187.4B
Enterprise Value $210.77B
Beta 0.58
Average Volume 9.92M
Shares Outstanding (Diluted) 1.74B
Shares Change YoY -0.63%
Institutional Ownership 82.29%
Exchange NYSE
ISIN US0028241000
Price Performance
Price Change 1M 11.1%
Price Change 3M 1.1%
Price Change 6M 23.7%
Price Change YTD -13.6%
Price Change 1Y -12.6%
Price Change 3Y 13.0%
Price Change 5Y -15.8%
1M CAGR (ann.) 4.1%
1Y CAGR (ann.) -12.5%
5Y CAGR (ann.) -1.5%
All-Time CAGR 12.2%
Valuation
PE Ratio 39.33
Forward PE 17.80
PEG Ratio -0.59
Forward PEG 5.55
PS Ratio 3.81
Forward PS 3.40
PB Ratio 3.60
P/FCF Ratio 21.07
P/Adj. FCF Ratio 22.97
P/OCF Ratio 18.63
EV/Sales 4.37
EV/EBIT 29.38
EV/EBITDA 21.71
EV/FCF 24.17
Earnings Yield 2.5%
FCF Yield 4.8%
Adj. FCF Yield 4.3%
Financial Health
Net Debt $27.01B
Total Debt $32.61B
Cash & Short-Term Investments $5.6B
Total Assets $109.22B
Current Ratio 1.38
Quick Ratio 0.97
Debt / Equity Ratio 0.64
Debt / EBITDA 3.36
Debt / FCF 3.74
OCF / Debt 0.30
Interest Coverage 8.26
Altman Z-Score 3.29
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 57.1%
Operating Profit Margin 15.2%
EBITDA Margin 20.1%
Net Profit Margin 9.8%
FCF Margin 18.1%
Adj. FCF Margin 16.6%
SBC / Revenue 1.5%
SBC Impact (per share) -8.2%
Returns
Return on Assets 4.3%
Return on Equity 9.1%
Return on Invested Capital 5.6%
Return on Capital Employed 8.0%
Return on Tangible Assets 8.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 6.5%
Revenue CAGR 5Y 2.6%
Revenue CAGR 10Y 8.8%
EPS CAGR 3Y -2.8%
EPS CAGR 5Y -7.7%
EPS CAGR 10Y 11.4%
FCF CAGR 3Y 16.7%
FCF CAGR 5Y 0.2%
FCF CAGR 10Y 17.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 21
EPS Growth Next 3Y 38.7%
Revenue Growth Next 3Y 8.4%
Earnings Date Jan 28, 2027
EPS Estimate (next Q) $1.64
EPS Growth Est (next Q) 9.3%
Revenue Est (next Q) $13.22B
Revenue Growth Est (next Q) 15.3%
Fair Value Estimates
Graham Number $42.53
Graham Upside -60.0%
Lynch Fair Value $13.50
Lynch Upside -87.3%
Price Target $121.36
Price Target Upside 14.3%
Cash Flow
Operating Cash Flow $9.91B
Free Cash Flow $8.72B
Adj. Free Cash Flow $8B
FCF Per Share $5.02
OCF Per Share $5.70
OCF/S Ratio 20.5%
Income Statement
Revenue $48.23B
Gross Profit $27.55B
Operating Income $7.35B
EBITDA $9.71B
Net Income $4.7B
EPS (Diluted) $2.70
Revenue / Employee $419.38K
Profit / Employee $40.88K
Employees 115,000
Dividends
Annual Dividend $2.52
Dividend Yield 2.37%
Payout Ratio 93.3%
FCF Payout Ratio 48.9%
Adj. FCF Payout Ratio 53.3%
Dividend Growth (YoY) 6.8%
Pay Frequency Quarterly
Ex-Dividend Date Oct 15, 2026
Add to Watchlist
Select watchlists to add or remove ABT